ASK1 inhibition: a therapeutic strategy with multi-system benefits JM Ogier, BA Nayagam, PJ Lockhart Journal of molecular medicine 98 (3), 335-348, 2020 | 85 | 2020 |
CHD7 Deficiency in “Looper”, a New Mouse Model of CHARGE Syndrome, Results in Ossicle Malformation, Otosclerosis and Hearing Impairment JM Ogier, MR Carpinelli, BD Arhatari, RCA Symons, BT Kile, RA Burt PloS one 9 (5), e97559, 2014 | 27 | 2014 |
Organotypic culture of neonatal murine inner ear explants JM Ogier, RA Burt, HR Drury, R Lim, BA Nayagam Frontiers in Cellular Neuroscience 13, 170, 2019 | 26 | 2019 |
Hearing function, degeneration, and disease: Spotlight on the stria vascularis MR Thulasiram, JM Ogier, A Dabdoub Frontiers in Cell and Developmental Biology 10, 841708, 2022 | 25 | 2022 |
Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice JM Ogier, PJ Lockhart, RA Burt Hearing research 386, 107870, 2020 | 13 | 2020 |
Mice haploinsufficient for Ets1 and Fli1 display middle ear abnormalities and model aspects of Jacobsen syndrome MR Carpinelli, EA Kruse, BD Arhatari, MA Debrincat, JM Ogier, JC Bories, ... The American Journal of Pathology 185 (7), 1867-1876, 2015 | 13 | 2015 |
An intronic mutation in Chd7 creates a cryptic splice site, causing aberrant splicing in a mouse model of CHARGE syndrome JM Ogier, BD Arhatari, MR Carpinelli, BK McColl, MA Wilson, RA Burt Scientific Reports 8 (1), 5482, 2018 | 9 | 2018 |
Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice J Manning, EM Dunne, N Wang, JS Pedersen, JM Ogier, RA Burt, ... Vaccine 37 (26), 3495-3504, 2019 | 7 | 2019 |
Extracellular Biomarkers of Inner Ear Disease and Their Potential for Point‐of‐Care Diagnostics SS Mahshid, AM Higazi, JM Ogier, A Dabdoub Advanced Science 9 (9), 2104033, 2022 | 4 | 2022 |
ASK1 is a novel molecular target for preventing aminoglycoside-induced hair cell death JM Ogier, Y Gao, EM Dunne, MA Wilson, SC Ranganathan, GH Tesch, ... Journal of Molecular Medicine 100 (5), 797-813, 2022 | 3 | 2022 |